Hansoh Pharmac Hd 00001 Stock Shares Owned By Insiders
| 3KY Stock | EUR 2.14 0.02 0.93% |
HANSOH PHARMAC HD 00001 fundamentals help investors to digest information that contributes to HANSOH PHARMAC's financial success or failures. It also enables traders to predict the movement of HANSOH Stock. The fundamental analysis module provides a way to measure HANSOH PHARMAC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HANSOH PHARMAC stock.
HANSOH |
HANSOH PHARMAC HD 00001 Company Shares Owned By Insiders Analysis
HANSOH PHARMAC's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current HANSOH PHARMAC Shares Owned By Insiders | 81.92 % |
Most of HANSOH PHARMAC's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HANSOH PHARMAC HD 00001 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 81% of HANSOH PHARMAC HD 00001 are shares owned by insiders. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares owned by insiders for all Germany stocks is notably lower than that of the firm.
HANSOH Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HANSOH PHARMAC's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HANSOH PHARMAC could also be used in its relative valuation, which is a method of valuing HANSOH PHARMAC by comparing valuation metrics of similar companies.HANSOH PHARMAC is number one stock in shares owned by insiders category among its peers.
HANSOH Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.063 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.28 % | |||
| Shares Outstanding | 5.92 B | |||
| Shares Owned By Insiders | 81.92 % | |||
| Shares Owned By Institutions | 7.99 % | |||
| Price To Earning | 38.60 X | |||
| Revenue | 9.97 B | |||
| Gross Profit | 9.06 B | |||
| EBITDA | 3.02 B | |||
| Net Income | 2.57 B | |||
| Cash And Equivalents | 13.73 B | |||
| Cash Per Share | 2.32 X | |||
| Total Debt | 92.75 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.43 X | |||
| Book Value Per Share | 3.57 X | |||
| Cash Flow From Operations | 2.39 B | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 10.78 K | |||
| Beta | 0.57 | |||
| Market Capitalization | 11.47 B | |||
| Z Score | 73.8 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.12 |
About HANSOH PHARMAC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HANSOH PHARMAC HD 00001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HANSOH PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HANSOH PHARMAC HD 00001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HANSOH Stock
HANSOH PHARMAC financial ratios help investors to determine whether HANSOH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HANSOH with respect to the benefits of owning HANSOH PHARMAC security.